title: The role of methotrexate in psoriatic arthritis: what is the evidence?
abstract: Methotrexate is a popular and widely used medication for the treatment of psoriatic arthritis. Herein we review the body of evidence for its use and examine its benefits as well as its limitations, both as a monotherapy and in combination with other DMARDs and biological drugs.
authors.affiliation: Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
authors.forename: Irina
authors.initials: I
authors.lastname: Ianculescu
authors.affiliation: Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, USA. weisman@cshs.org.
authors.forename: Michael H
authors.initials: MH
authors.lastname: Weisman
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use; D015535:Arthritis, Psoriatic / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D001688:Biological Products / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D019317:Evidence-Based Medicine; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D008727:Methotrexate / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D018501:Antirheumatic Agents; D001688:Biological Products; D007166:Immunosuppressive Agents; D008727:Methotrexate